Background and Objective. Small lymphocytic lymphoma (SLL) is morpholo
gically and immunological ly similar to chronic lymphocytic leukemia (
CLL), and the new REAL classification refers to them as a single disea
se termed SLL/CLL. Recently, frequent losses in 6q, 11q and/or 13q wer
e observed in CLL using comparative genomic hybridization (CGH).(1) We
performed CGH analyses in order to find out whether these two entitie
s contain the same DNA copy number changes. Design and Methods. Sevent
een patients with stage IV disease and one with stage III disease were
studied by CGH. CGH is based on quantitation of the fluorescence inte
nsity of differentially labeled DNAs. For this purpose tumor DNA label
ed with FITC-12dUTP and normal DNA labeled with texas red-5dUTF were h
ybridized to normal metaphase chromosomes. the ratio of fluorescence i
ntensity of hybridized tumor and normal DNA was measured using compute
rized image microscopy to identify over- or under-represented regions
in the tumor genome. All findings were confirmed using a confidence in
terval of 99% with a 1% error probability. Results. The most consisten
t finding was a gain of the entire chromosome 12 observed in three pat
ients and a loss in 14q24 in one patient. No other changes were detect
ed. All abnormal cases presented with stage IV disease and had bone ma
rrow infiltration. Two 12+ cases had a leukemic disease. Interpretatio
n and Conclusions. Our results indicate that trisomy 12 is one of the
most frequent chromosomal aberrations in SLL. Losses regarded as typic
al of CLL were not present in SLL. This may indicate that the genetic
pathways in the development of SLL/CLL in patients presenting with enl
arged lymph nodes (SLL) with or without leukemia are different from th
ose in patients presenting with leukemia (CLL) without enlarged lymph
nodes. (C) 1998, Ferrata Storti Foundation.